These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25284742)

  • 1. Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans.
    Paulin R; Dromparis P; Sutendra G; Gurtu V; Zervopoulos S; Bowers L; Haromy A; Webster L; Provencher S; Bonnet S; Michelakis ED
    Cell Metab; 2014 Nov; 20(5):827-839. PubMed ID: 25284742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
    Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
    McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
    J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension.
    Niihori M; James J; Varghese MV; McClain N; Lawal OS; Philip RC; Baggett BK; Goncharov DA; de Jesus Perez V; Goncharova EA; Rafikov R; Rafikova O
    J Exp Med; 2024 Nov; 221(11):. PubMed ID: 39320470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
    Shi Z; Wu H; Luo J; Sun X
    Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic theory of pulmonary arterial hypertension.
    Paulin R; Michelakis ED
    Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.
    Meloche J; Potus F; Vaillancourt M; Bourgeois A; Johnson I; Deschamps L; Chabot S; Ruffenach G; Henry S; Breuils-Bonnet S; Tremblay È; Nadeau V; Lambert C; Paradis R; Provencher S; Bonnet S
    Circ Res; 2015 Aug; 117(6):525-35. PubMed ID: 26224795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.
    Ryan JJ; Marsboom G; Fang YH; Toth PT; Morrow E; Luo N; Piao L; Hong Z; Ericson K; Zhang HJ; Han M; Haney CR; Chen CT; Sharp WW; Archer SL
    Am J Respir Crit Care Med; 2013 Apr; 187(8):865-78. PubMed ID: 23449689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Jheng JR; Bai Y; Noda K; Huot JR; Cook T; Fisher A; Chen YY; Goncharov DA; Goncharova EA; Simon MA; Zhang Y; Forman DE; Rojas M; Machado RF; Auwerx J; Gladwin MT; Lai YC
    Circulation; 2024 Sep; 150(11):867-883. PubMed ID: 38804138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene.
    Said SI; Hamidi SA; Dickman KG; Szema AM; Lyubsky S; Lin RZ; Jiang YP; Chen JJ; Waschek JA; Kort S
    Circulation; 2007 Mar; 115(10):1260-8. PubMed ID: 17309917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
    Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model Lacking Both Genes.
    Zhang Y; Zervopoulos SD; Boukouris AE; Lorenzana-Carrillo MA; Saleme B; Webster L; Liu Y; Haromy A; Tabatabaei Dakhili SA; Ussher JR; Sutendra G; Michelakis ED
    J Am Heart Assoc; 2021 Dec; 10(23):e020451. PubMed ID: 34719264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
    Michelakis ED; Gurtu V; Webster L; Barnes G; Watson G; Howard L; Cupitt J; Paterson I; Thompson RB; Chow K; O'Regan DP; Zhao L; Wharton J; Kiely DG; Kinnaird A; Boukouris AE; White C; Nagendran J; Freed DH; Wort SJ; Gibbs JSR; Wilkins MR
    Sci Transl Med; 2017 Oct; 9(413):. PubMed ID: 29070699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
    Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
    Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
    Moudgil R; Michelakis ED; Archer SL
    Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.
    Li Q; Qian Z; Wang L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1351-1361. PubMed ID: 28496318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.